Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05612464
Other study ID # 317454
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date February 1, 2023
Est. completion date February 1, 2028

Study information

Verified date October 2022
Source King's College London
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Dystonia is a severely disabling movement disorder with no cure, in which people suffer painful muscle spasms causing twisting movements and abnormal postures. There are many causes, including genetic conditions and brain injury. The most common cause in childhood is dystonic cerebral palsy (CP) which often affects the whole body. The underlying mechanisms are unknown, but there is growing evidence to implicate abnormal brain processing by the brain of incoming "sensory" information (e.g., signals to the brain from our senses of touch and body position): the distorted perception of these signals disrupts the way the brain produces instructions for planning and performing movements. The investigator's previous studies have shown that the way the brain processes sensory information related to movement is abnormal in children with dystonia and dystonic CP, by using methods that record the EEG (electroencephalogram - brain wave signals) and/or EMG (electromyogram - electrical signal from muscles). A specific brain rhythm (called mu) typically shows well-defined changes in response to movement, and reflects processing of sensory information. The investigator's work shows these rhythm changes are abnormal in children with dystonia/dystonic CP. This study will explore if these findings can improve treatment. In particular the study team will investigate whether children and young people with dystonia/dystonic CP can enhance these mu rhythm responses during a movement task by using feedback of their brain rhythms displayed as a cartoon/game on a computer. The investigators will also assess whether enhanced mu activity is associated with improved movement control. This would open future possibilities to use such devices for therapy/rehabilitation. Children and young people with dystonia/dystonic CP aged 5-25 years will be recruited, along with age-matched controls. Studies will last 2-3 hours with time for breaks and will be conducted at Evelina London Children's Hospital and Barts Health Trust, with the option for home visits if preferable for families.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 90
Est. completion date February 1, 2028
Est. primary completion date February 1, 2028
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 25 Years
Eligibility Key inclusion criteria Control Group: - Age 5 -25 years - No known disorder of movement - Able to understand and participate in study. Primary dystonia group (isolated genetic or idiopathic): - Age 5-25 years - Clinical dystonia - as confirmed on clinical assessment by consultant paediatric neurologist. - Genetic or idiopathic aetiology. - No other neurological abnormality. - Normal cranial magnetic resonance imaging (MRI). - Able to understand and participate in study. Dystonic Cerebral Palsy Group: - Age 5-25 years - Clinical dystonia/dyskinesia - as confirmed on clinical assessment by consultant paediatric neurologist. - Documented history of perinatal hypoxic-ischaemic encephalopathy (HIE), prematurity <35 weeks or kernicterus. - Predominant dystonia/dyskinesia / Minimal spasticity - MRI findings in keeping with acute perinatal HIE, prematurity or kernicterus (including classical pattern of damage to thalami, basal ganglia and peri-rolandic cortex, periventricular leukomalacia or ischaemic parenchymal injury). - Able to understand and participate in study. Key exclusion criteria Control Group: - Age <5 or >25 years - Any known disorder of movement. Primary dystonia group (isolated genetic or idiopathic): - Age < 5 or >25 years - Presence of other neurological abnormality in addition to dystonia. - Abnormal cranial MRI. Dystonic Cerebral Palsy Group: - Age < 5 or >25 years - No clear history of perinatal HIE, prematurity or kernicterus. - Predominant spasticity. - MRI scan not compatible with perinatal HIE, prematurity or kernicterus

Study Design


Intervention

Other:
No intervention
No intervention

Locations

Country Name City State
n/a

Sponsors (6)

Lead Sponsor Collaborator
King's College London Barts & The London NHS Trust, Guy's and St Thomas' NHS Foundation Trust, Imperial College London, University of Bristol, University of Calgary

Outcome

Type Measure Description Time frame Safety issue
Primary Change in mu modulation between trials with and without biofeedback During the procedure
See also
  Status Clinical Trial Phase
Completed NCT01433757 - Ampicillin for DYT-1 Dystonia Motor Symptoms Phase 1
Recruiting NCT00971854 - Alteration of Deep Brain Stimulation Parameters for Dystonia N/A
Enrolling by invitation NCT00355927 - Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders. N/A
Completed NCT00169338 - Pallidal Stimulation in Patients With Post-anoxic and Idiopathic Dystonia Phase 2
Completed NCT00004421 - Deep Brain Stimulation in Treating Patients With Dystonia Phase 2/Phase 3
Terminated NCT03270189 - Effect of the Visual Information Change in Functional Dystonia N/A
Recruiting NCT02583074 - Clinical Trial of STN-DBS for Primary Cranial-Cervical Dystonia N/A
Recruiting NCT06117020 - Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals Phase 1
Completed NCT01432899 - Studying Childhood-Onset Hemidystonia
Completed NCT04948684 - Efficacy of Botulinum Toxin for the Treatment of Dystonia Associated With Parkinson's Disease and Atypical Parkinsonism
Completed NCT05106816 - The Effects of Vibrotactile Stimulation in Patients With Movement Disorders N/A
Recruiting NCT05027997 - Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm Phase 2
Completed NCT00465790 - Research of Biomarkers in Parkinson Disease Phase 0
Active, not recruiting NCT00142259 - Efficacy and Safety of DBS of the GPi in Patients With Primary Generalized and Segmental Dystonia Phase 4
Recruiting NCT05663840 - Effects of Exercise on Dystonia Pathophysiology N/A
Not yet recruiting NCT06038097 - Efficacy and Safety of Radiofrequency Pallidotomy in the Management of Dystonia N/A
Recruiting NCT04286308 - Cortical-Basal Ganglia Speech Networks N/A
Active, not recruiting NCT03582891 - The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy N/A
Completed NCT03318120 - Exercise Training in Dystonia N/A
Completed NCT04568681 - Deep Brain Stimulation Effects in Dystonia